BR0016223A - Amicomicina, processo para sua produção e seu uso como farmacêutico - Google Patents

Amicomicina, processo para sua produção e seu uso como farmacêutico

Info

Publication number
BR0016223A
BR0016223A BR0016223-0A BR0016223A BR0016223A BR 0016223 A BR0016223 A BR 0016223A BR 0016223 A BR0016223 A BR 0016223A BR 0016223 A BR0016223 A BR 0016223A
Authority
BR
Brazil
Prior art keywords
amicomycin
pharmacist
production
amycomycin
stereoisomeric
Prior art date
Application number
BR0016223-0A
Other languages
English (en)
Inventor
Cordula Hopmann
Michael Kurz
Heinrich Decker
Dominique Le Beller
Jozsef Aszodi
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0016223A publication Critical patent/BR0016223A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"AMICOMICINA, PROCESSO PARA SUA PRODUçãO E SEU USO COMO FARMACêUTICO". Um composto chamado amicomicina de fórmula (I) e seus sais e derivados farmaceuticamente aceitáveis, em todas as suas formas estereoisoméricas e tautoméricas é obtenível por cultivo do microorganismo Amycolatopsis sp., ST101170 (DSM 12216) e tem utilidade como farmacêutico, particularmente como antibiótico.
BR0016223-0A 1999-12-08 2000-11-25 Amicomicina, processo para sua produção e seu uso como farmacêutico BR0016223A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical
PCT/EP2000/011752 WO2001042210A1 (en) 1999-12-08 2000-11-25 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (1)

Publication Number Publication Date
BR0016223A true BR0016223A (pt) 2002-09-10

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016223-0A BR0016223A (pt) 1999-12-08 2000-11-25 Amicomicina, processo para sua produção e seu uso como farmacêutico

Country Status (27)

Country Link
US (1) US6642391B2 (pt)
EP (2) EP1106604A1 (pt)
JP (1) JP4750993B2 (pt)
KR (1) KR100728514B1 (pt)
CN (1) CN1217929C (pt)
AT (1) ATE298744T1 (pt)
AU (1) AU781398B2 (pt)
BR (1) BR0016223A (pt)
CA (1) CA2393518C (pt)
CZ (1) CZ294370B6 (pt)
DE (1) DE60021109T2 (pt)
DK (1) DK1237866T3 (pt)
EE (1) EE05219B1 (pt)
ES (1) ES2243332T3 (pt)
HR (1) HRP20020497B1 (pt)
HU (1) HU225194B1 (pt)
IL (2) IL149904A0 (pt)
ME (1) MEP28508A (pt)
NO (1) NO322565B1 (pt)
PL (1) PL201809B1 (pt)
PT (1) PT1237866E (pt)
RS (1) RS50288B (pt)
RU (1) RU2261916C2 (pt)
SI (1) SI1237866T1 (pt)
SK (1) SK286776B6 (pt)
WO (1) WO2001042210A1 (pt)
ZA (1) ZA200204420B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2392325C2 (ru) * 2008-05-07 2010-06-20 Государственное учреждение научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе РАМН (ГУ НИИНА им. Г.Ф. Гаузе РАМН) Штамм amycolatopsis fructiferi subsp. ristomycini - продуцент антибиотика ристомицина
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、ｍｉ７１０−５１ｆ６物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質ｍｉ４８１−４２ｆ４−ａ及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンｂおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンａおよびｂとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
HUP0203593A2 (hu) 2003-02-28
SK286776B6 (sk) 2009-05-07
AU2001901A (en) 2001-06-18
CN1217929C (zh) 2005-09-07
JP4750993B2 (ja) 2011-08-17
HK1048998A1 (en) 2003-04-25
EE05219B1 (et) 2009-10-15
PL355627A1 (en) 2004-05-04
ATE298744T1 (de) 2005-07-15
DE60021109T2 (de) 2006-05-04
US20010018450A1 (en) 2001-08-30
HU225194B1 (en) 2006-08-28
ME00182B (me) 2010-10-10
NO20022654L (no) 2002-06-05
HRP20020497A2 (en) 2004-08-31
NO322565B1 (no) 2006-10-23
HRP20020497B1 (hr) 2006-04-30
CN1377341A (zh) 2002-10-30
RU2002118116A (ru) 2004-02-27
IL149904A (en) 2007-10-31
EP1237866A1 (en) 2002-09-11
NO20022654D0 (no) 2002-06-05
IL149904A0 (en) 2002-11-10
EE200200280A (et) 2003-06-16
US6642391B2 (en) 2003-11-04
DK1237866T3 (da) 2005-10-10
RU2261916C2 (ru) 2005-10-10
YU13102A (sh) 2005-06-10
SI1237866T1 (en) 2005-10-31
SK7872002A3 (en) 2002-11-06
KR20020063205A (ko) 2002-08-01
CZ20021891A3 (cs) 2002-08-14
RS50288B (sr) 2009-09-08
PT1237866E (pt) 2005-10-31
WO2001042210A1 (en) 2001-06-14
AU781398B2 (en) 2005-05-19
EP1106604A1 (en) 2001-06-13
HUP0203593A3 (en) 2003-12-29
KR100728514B1 (ko) 2007-06-15
JP2003516389A (ja) 2003-05-13
ZA200204420B (en) 2003-09-03
MEP28508A (en) 2010-10-10
CA2393518C (en) 2009-01-20
CZ294370B6 (cs) 2004-12-15
EP1237866B1 (en) 2005-06-29
CA2393518A1 (en) 2001-06-14
PL201809B1 (pl) 2009-05-29
ES2243332T3 (es) 2005-12-01
DE60021109D1 (de) 2005-08-04

Similar Documents

Publication Publication Date Title
BR9910928A (pt) Composto, processo para a prepará-lo, uso do mesmo, formulação, e, processo para a profilaxia e/ou tratamento de condições clinicas associadas com resistência a insulina
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
GEP19991836B (en) Novel Erythromicin Derivatives, Method for Preparing Same and Pharmaceutical Composition on its Basis
GR3022981T3 (en) Process for the preparation of clavulinic acid and pharmaceutically acceptable salts from fermentation broths of Streptomyces sp.
NO890567D0 (no) Anthracyklin-derivater.
AU2001240578A1 (en) Pharmaceutically active aromatic guanylhydrazones
DE69915487D1 (de) Erythromycin-derivate mit antibiotischer wirkung
BR0016223A (pt) Amicomicina, processo para sua produção e seu uso como farmacêutico
BR0015877A (pt) Polimorfo v de torasemida
EP1211251A4 (en) CHROMONE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
BR0017175A (pt) Modificação da torasemida amorfa
AU2001258488A1 (en) Uridine derivatives as antibiotics
BR9916888A (pt) Uso de compostos e seus sais com ácidosfarmacologicamente aceitáveis
ES2181506T3 (es) Vancoresmicina, un procedimiento para su produccion y su uso como producto farmaceutico.
AR026715A1 (es) Amicomicina, un proceso para su produccion y su uso como un producto farmaceutico.
ES2108444T3 (es) Antibioticos aglucodalbaheptidos sinteticos.
AU2001256294A1 (en) Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
TR200000244T2 (tr) MCP-1 proteini üretimini azaltmada etkin bir farmasötik bileşim.
DE69912959D1 (de) Eythromycinderivat mit antibiotischer aktvität
BR122015020406B8 (pt) uso de compostos de formula i como inibidores de beta-lactamases e composições farmaceuticas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: NOME ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements